About Athena Countouriotis
Form D filings for Capstan Therapeutics in 2024 list Athena Countouriotis as director.
Athena Countouriotis first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Athena Countouriotis in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Athena Countouriotis works with at each company, as listed on that company's latest Form D.
Capstan Therapeutics, Inc. · Form D, Mar 20, 2024
FP
Fabio Pucci
Director
NS
Nandita Shangari
Director
MS
Michal Silverberg
Director
Erez Chimovits
Director
RJ
Rajul Jain
Director
LS
Laura Shawver
President and CEO, director
RF
Ramin Farzaneh-Far
Executive officer
JT
Justin Thacker
Executive officer
MB
Michael Baran
Director
AB
Adrian Bot
Executive officer
NL
Nanna Luneborg
Director
PK
Priya Karmali
Executive officer
KS
Karen Smith
Director